ERBB2 is up-regulated in multiple tumors located in breast, bladder, pancreas, ovary, and esophagus, especially in tumors with poor prognostic characteristics; in breast cancer, high expression of ERBB2 has become one of the hallmarks of poor prognosis (Dawood et al., 2009). This evidence concerns the gene ERBB2 and breast cancer.